UAB To Test Potential COVID-19 Vaccine

 ========= Old Image Removed =========Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2020/03/COVIDresearch2-e1585604335787.jpg
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:5:{s:5:"width";i:600;s:6:"height";i:337;s:4:"file";s:41:"2020/03/COVIDresearch2-e1585604335787.jpg";s:5:"sizes";a:8:{s:9:"thumbnail";a:4:{s:4:"file";s:41:"COVIDresearch2-e1585604335787-140x140.jpg";s:5:"width";i:140;s:6:"height";i:140;s:9:"mime-type";s:10:"image/jpeg";}s:6:"medium";a:4:{s:4:"file";s:41:"COVIDresearch2-e1585604335787-336x189.jpg";s:5:"width";i:336;s:6:"height";i:189;s:9:"mime-type";s:10:"image/jpeg";}s:9:"wbhm-icon";a:4:{s:4:"file";s:39:"COVIDresearch2-e1585604335787-80x80.jpg";s:5:"width";i:80;s:6:"height";i:80;s:9:"mime-type";s:10:"image/jpeg";}s:13:"wbhm-featured";a:4:{s:4:"file";s:41:"COVIDresearch2-e1585604335787-600x337.jpg";s:5:"width";i:600;s:6:"height";i:337;s:9:"mime-type";s:10:"image/jpeg";}s:20:"wbhm-featured-square";a:4:{s:4:"file";s:41:"COVIDresearch2-e1585604335787-300x300.jpg";s:5:"width";i:300;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:18:"wbhm-featured-home";a:4:{s:4:"file";s:41:"COVIDresearch2-e1585604335787-554x311.jpg";s:5:"width";i:554;s:6:"height";i:311;s:9:"mime-type";s:10:"image/jpeg";}s:22:"wbhm-featured-carousel";a:4:{s:4:"file";s:41:"COVIDresearch2-e1585604335787-470x265.jpg";s:5:"width";i:470;s:6:"height";i:265;s:9:"mime-type";s:10:"image/jpeg";}s:14:"post-thumbnail";a:4:{s:4:"file";s:41:"COVIDresearch2-e1585604335787-125x125.jpg";s:5:"width";i:125;s:6:"height";i:125;s:9:"mime-type";s:10:"image/jpeg";}}s:10:"image_meta";a:12:{s:8:"aperture";s:3:"2.8";s:6:"credit";s:12:"Getty Images";s:6:"camera";s:9:"ILCE-7RM3";s:7:"caption";s:71:"Back view of Scientist testing Vaccine Coronavirus in Biosafety Cabinet";s:17:"created_timestamp";s:10:"1583682993";s:9:"copyright";s:0:"";s:12:"focal_length";s:2:"32";s:3:"iso";s:3:"320";s:13:"shutter_speed";s:4:"0.01";s:5:"title";s:71:"Back view of Scientist testing Vaccine Coronavirus in Biosafety Cabinet";s:11:"orientation";s:1:"1";s:8:"keywords";a:0:{}}}
        )

    [_media_credit] => Array
        (
            [0] => The University of Alabama at Birmingham
        )

    [_navis_media_credit_org] => Array
        (
            [0] => 
        )

    [_navis_media_can_distribute] => Array
        (
            [0] => 
        )

    [_wp_attachment_backup_sizes] => Array
        (
            [0] => a:9:{s:9:"full-orig";a:3:{s:5:"width";i:600;s:6:"height";i:451;s:4:"file";s:18:"COVIDresearch2.jpg";}s:14:"thumbnail-orig";a:4:{s:4:"file";s:26:"COVIDresearch2-140x140.jpg";s:5:"width";i:140;s:6:"height";i:140;s:9:"mime-type";s:10:"image/jpeg";}s:11:"medium-orig";a:4:{s:4:"file";s:26:"COVIDresearch2-336x253.jpg";s:5:"width";i:336;s:6:"height";i:253;s:9:"mime-type";s:10:"image/jpeg";}s:14:"wbhm-icon-orig";a:4:{s:4:"file";s:24:"COVIDresearch2-80x80.jpg";s:5:"width";i:80;s:6:"height";i:80;s:9:"mime-type";s:10:"image/jpeg";}s:18:"wbhm-featured-orig";a:4:{s:4:"file";s:26:"COVIDresearch2-600x338.jpg";s:5:"width";i:600;s:6:"height";i:338;s:9:"mime-type";s:10:"image/jpeg";}s:25:"wbhm-featured-square-orig";a:4:{s:4:"file";s:26:"COVIDresearch2-300x300.jpg";s:5:"width";i:300;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:23:"wbhm-featured-home-orig";a:4:{s:4:"file";s:26:"COVIDresearch2-414x311.jpg";s:5:"width";i:414;s:6:"height";i:311;s:9:"mime-type";s:10:"image/jpeg";}s:27:"wbhm-featured-carousel-orig";a:4:{s:4:"file";s:26:"COVIDresearch2-353x265.jpg";s:5:"width";i:353;s:6:"height";i:265;s:9:"mime-type";s:10:"image/jpeg";}s:19:"post-thumbnail-orig";a:4:{s:4:"file";s:26:"COVIDresearch2-125x125.jpg";s:5:"width";i:125;s:6:"height";i:125;s:9:"mime-type";s:10:"image/jpeg";}}
        )

)
1624218082 
1585586365

By BirminghamWatch

The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.

Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.

The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.

The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”

“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.

Lund said six labs at UAB will work on the project.

Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.

“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.

UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.

“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.

 

Rickwood Field, a time capsule of opportunity and oppression, welcomes MLB for Negro Leagues tribute

Rickwood Field, the oldest professional ballpark in the U.S. and former home to baseball Hall of Famer Willie Mays and the Birmingham Black Barons of the Negro Leagues, will host an MLB game between the St. Louis Cardinals and San Francisco Giants on Thursday.

Alabama native Willie Mays, Giants’ electrifying ‘Say Hey Kid’ has died at 93

Mays' family and the San Francisco Giants jointly announced Tuesday night he had died earlier in the afternoon in the Bay Area.

What does Juneteenth mean to you?

Wednesday is Juneteenth. a holiday that commemorates the end of slavery in the U.S. The date goes back to 1865 when enslaved people in Galveston, Texas, learned of their emancipation.  During our recent News and Brews community pop-up at the Birmingham Civil Rights Institute, we asked people what Juneteenth means to them.

Hall of Famer Willie Mays will not be in attendance for Negro League tribute game at Rickwood Field

Mays, who began his career in Alabama with the Birmingham Black Barons of the Negro Leagues and played for the Giants from 1951-72, told the San Francisco Chronicle that he will enjoy the game at home.

As dollar stores continue rural expansion, a Louisiana parish found a new way to push back

Tangipahoa Parish blocked a new Dollar General from opening in a case that could set a precedent for other communities looking to keep discount retailers out.

A family’s search for their native and formerly enslaved heritage in South Alabama

The Tate Family has spent nearly two decades uncovering records that establish their ancestors' time in Alabama before its statehood.

More BirminghamWatch Coverage